You reviewed ....
for this content
out of 5
Select Select events(s)
Select Resource type(s)
2-year real-world outcomes of prasugrel, ticagrelor or clopidogrel therapy following percutaneous coronary intervention from a large multi-centre Australian registry.
ESC Asia 2020
2020 ESC Guidelines on Atrial Fibrillation.
2020 ESC Guidelines on Non-ST-Segment Elevation Acute Coronary Syndromes.
2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease.
3D right ventricular ejection fraction and longitudinal strain are independent predictors of major adverse cardiovascular events in patients with rrhythmogenic right ventricular cardiomyopathy
A novel pressure-regulated deployment strategy for improving the safety and efficacy of balloon-expandable transcatheter aortic valves
A novel therapeutic approach for coronary inflammation and lymphatic vessels using non-invasive low-intensity pulsed ultrasound in a porcine model with DES-induced coronary hyperconstricting responses
A real-world comparison of outcomes between fractional flow reserve-guided versus angiography-guided percutaneous coronary intervention
Adipokine omentin-1 enhances atherosclerotic plaque stability by binding to macrophage integrin receptor
Adipose extracellular signal-regulated kinase 2 protected from endothelial dysfunction and the oxidative stress of perivascular adipose tissue in obese mice
Get your access to resources
Our mission: To reduce the burden of cardiovascular disease